| Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification AN Nicolaides, SK Kakkos, E Kyriacou, M Griffin, M Sabetai, DJ Thomas, ... Journal of vascular surgery 52 (6), 1486-1496. e5, 2010 | 381 | 2010 |
| Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults M Pfeifer, R Verhovec, B Zizek, J Prezelj, P Poredos, RN Clayton The Journal of Clinical Endocrinology & Metabolism 84 (2), 453-457, 1999 | 376 | 1999 |
| Intima-media thickness: indicator of cardiovascular risk and measure of the extent of atherosclerosis P Poredos Vascular Medicine 9 (1), 46-54, 2004 | 273 | 2004 |
| ESVM Guideline on peripheral arterial disease U Frank, S Nikol, J Belch, V Boc, M Brodmann, PH Carpentier, A Chraim, ... Vasa, 2019 | 266 | 2019 |
| Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study AN Nicolaides, SK Kakkos, M Griffin, M Sabetai, S Dhanjil, T Tegos, ... European journal of vascular and endovascular surgery 30 (3), 275-284, 2005 | 260 | 2005 |
| Non-coronary atherosclerosis A Gallino, V Aboyans, C Diehm, F Cosentino, H Stricker, E Falk, ... European heart journal 35 (17), 1112-1119, 2014 | 240 | 2014 |
| Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction P Poredoš, M Orehek, E Tratnik, P Poredoš Angiology 50 (3), 201-208, 1999 | 220 | 1999 |
| The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients P Poredoš, B Jug Angiology 58 (3), 309-315, 2007 | 203 | 2007 |
| Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European independent foundation in angiology … GT Gerotziafas, M Catalano, MP Colgan, Z Pecsvarady, JC Wautrecht, ... Thrombosis and haemostasis 120 (12), 1597-1628, 2020 | 184 | 2020 |
| Testing endothelial function and its clinical relevance P Poredos, MK Jezovnik Journal of atherosclerosis and thrombosis 20 (1), 1-8, 2013 | 182 | 2013 |
| Endothelial dysfunction in the pathogenesis of atherosclerosis P Poredos International Angiology 21 (2), 109, 2002 | 169 | 2002 |
| The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis P Poredos, MK Jezovnik International angiology 26 (4), 306, 2007 | 141 | 2007 |
| Endothelial dysfunction and cardiovascular disease P Poredoš Pathophysiology of haemostasis and thrombosis 32 (5-6), 274-277, 2002 | 139 | 2002 |
| State-of-the-art review: endothelial dysfunction in the pathogenesis of atherosclerosis P Poredoš Clinical and Applied Thrombosis/Hemostasis 7 (4), 276-280, 2001 | 111 | 2001 |
| ESVM guidelines-the diagnosis and management of Raynaud's phenomenon J Belch, A Carlizza, PH Carpentier, J Constans, F Khan, JC Wautrecht, ... Vasa 46 (6), 413-423, 2017 | 107 | 2017 |
| Superficial vein thrombosis: a consensus statement E Kalodiki, V Stvrtinova, C Allegra, G Andreozzi, PL Antignani, R Avram, ... Int angiol 31 (3), 203-16, 2012 | 95 | 2012 |
| Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction MK Jezovnik, P Poredos International angiology 29 (3), 226, 2010 | 94 | 2010 |
| Endothelial dysfunction and venous thrombosis P Poredos, MK Jezovnik Angiology 69 (7), 564-567, 2018 | 86 | 2018 |
| Endothelial dysfunction in hypertensive patients and in normotensive offspring of subjects with essential hypertension B Žižek, P Poredoš, V Videčnik Heart 85 (2), 215-217, 2001 | 86 | 2001 |
| Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis J Dormandy, M Mahir, G Acsady, F Balsano, P De Leeuw, P Blombery, ... Thrombosis and haemostasis 81 (05), 715-722, 1999 | 79 | 1999 |
